U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H30Cl2N6O2S
Molecular Weight 537.505
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Zelenirstat

SMILES

CC(C)CC1=NN(C)C(C)=C1NS(=O)(=O)C2=C(Cl)C=C(C=C2Cl)C3=CC=NC(=C3)N4CCNCC4

InChI

InChIKey=WKTSLVQYGBHNRV-UHFFFAOYSA-N
InChI=1S/C24H30Cl2N6O2S/c1-15(2)11-21-23(16(3)31(4)29-21)30-35(33,34)24-19(25)12-18(13-20(24)26)17-5-6-28-22(14-17)32-9-7-27-8-10-32/h5-6,12-15,27,30H,7-11H2,1-4H3

HIDE SMILES / InChI

Molecular Formula C24H30Cl2N6O2S
Molecular Weight 537.505
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1767 ng/mL
210 mg single, oral
dose: 210 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PCLX-001 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2935 ng/mL
210 mg 1 times / day multiple, oral
dose: 210 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
PCLX-001 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
14654 ng × h/mL
210 mg single, oral
dose: 210 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PCLX-001 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
27558 ng × h/mL
210 mg 1 times / day multiple, oral
dose: 210 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
PCLX-001 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
7.8 h
210 mg single, oral
dose: 210 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PCLX-001 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
7.7 h
210 mg 1 times / day multiple, oral
dose: 210 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
PCLX-001 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Substance Class Chemical
Created
by admin
on Wed Apr 02 15:20:38 GMT 2025
Edited
by admin
on Wed Apr 02 15:20:38 GMT 2025
Record UNII
5HY8BYC3Q6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CCI-002
Preferred Name English
Zelenirstat
INN  
Official Name English
2,6-Dichloro-N-[1,5-dimethyl-3-(2-methylpropyl)-1H-pyrazol-4-yl]-4-[2-(1-piperazinyl)-4-pyridinyl]benzenesulfonamide
Systematic Name English
Benzenesulfonamide, 2,6-dichloro-N-[1,5-dimethyl-3-(2-methylpropyl)-1H-pyrazol-4-yl]-4-[2-(1-piperazinyl)-4-pyridinyl]-
Systematic Name English
PCLX 001 [WHO-DD]
Common Name English
PCLX-001
Code English
DDD86481
Code English
2,6-dichloro-N-[1,5-dimethyl-3-(2-methylpropyl)-1Hpyrazol-4-yl]-4-[2-(piperazin-1-yl)pyridin-4-yl]benzene-1-sulfonamide
Systematic Name English
DDD-86481
Code English
zelenirstat [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 904722
Created by admin on Wed Apr 02 15:20:38 GMT 2025 , Edited by admin on Wed Apr 02 15:20:38 GMT 2025
Code System Code Type Description
INN
12737
Created by admin on Wed Apr 02 15:20:38 GMT 2025 , Edited by admin on Wed Apr 02 15:20:38 GMT 2025
PRIMARY
NCI_THESAURUS
C180576
Created by admin on Wed Apr 02 15:20:38 GMT 2025 , Edited by admin on Wed Apr 02 15:20:38 GMT 2025
PRIMARY
SMS_ID
300000054573
Created by admin on Wed Apr 02 15:20:38 GMT 2025 , Edited by admin on Wed Apr 02 15:20:38 GMT 2025
PRIMARY
FDA UNII
5HY8BYC3Q6
Created by admin on Wed Apr 02 15:20:38 GMT 2025 , Edited by admin on Wed Apr 02 15:20:38 GMT 2025
PRIMARY
PUBCHEM
58561243
Created by admin on Wed Apr 02 15:20:38 GMT 2025 , Edited by admin on Wed Apr 02 15:20:38 GMT 2025
PRIMARY
CAS
1215011-08-7
Created by admin on Wed Apr 02 15:20:38 GMT 2025 , Edited by admin on Wed Apr 02 15:20:38 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY